Syschem (India), a company in the Pharmaceuticals industry, reported revenue of ₹113 crore and net profit of ₹1.91 crore for the September 2026 quarter.
Syschem (India) (BSE: SYSCHEM) closed at ₹30.68 on 20 Nov 2026, down 46.0% over the past year. Its market capitalisation is ₹164 crore and it trades at 26.7 times earnings.
Incorporated in 1993, Syschem (India) Limited manufactures Active Pharmaceuticals Ingredients (APIs) and bulk drugs.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.